Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

ClinicalTrials.gov ID: NCT02607956

Public ClinicalTrials.gov record NCT02607956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 3:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Study identification

NCT ID
NCT02607956
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
657 participants

Conditions and interventions

Interventions

  • DTG Drug
  • F/TAF Drug
  • B/F/TAF Drug
  • DTG Placebo Drug
  • F/TAF Placebo Drug
  • B/F/TAF Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2015
Primary completion
May 11, 2017
Completion
Jul 4, 2021
Last update posted
Mar 6, 2022

2015 – 2021

United States locations

U.S. sites
74
U.S. states
21
U.S. cities
56
Facility City State ZIP Site status
Not listed Phoenix Arizona 85012
Not listed Phoenix Arizona 85025
Not listed Beverly Hills California 90211
Not listed Los Angeles California 90027
Not listed Los Angeles California 90036
Not listed Los Angeles California 90059
Not listed Los Angeles California 90069
Not listed Sacramento California 95817
Not listed Sacramento California 95825
Optimus Medical - ClinEdge - PPDS San Francisco California 94102
Kaiser Permanente San Leandro California 94577
Not listed Denver Colorado 80205
Not listed Washington D.C. District of Columbia 20009
Not listed Washington D.C. District of Columbia 20036
Not listed Washington D.C. District of Columbia 20037
Not listed DeLand Florida 32720
Not listed Fort Lauderdale Florida 33316
Not listed Ft. Pierce Florida 34982
Not listed Miami Florida 33133
Not listed Miami Florida 33136
Not listed Miami Beach Florida 33139
Not listed Oakland Park Florida 33306
Not listed Orlando Florida 32803
Not listed Pensacola Florida 32504
Not listed Tampa Florida 33614
Not listed West Palm Beach Florida 33407
Not listed Atlanta Georgia 30308
Not listed Atlanta Georgia 30312
Not listed Decatur Georgia 30033
Not listed Macon Georgia 31201
Not listed Savannah Georgia 31405
Not listed Chicago Illinois 60613
Not listed Chicago Illinois 60657
Not listed Indianapolis Indiana 46202
Sinai Hospital of Baltimore Baltimore Maryland 21215
Not listed Boston Massachusetts 02129
Not listed Boston Massachusetts 02215
Not listed Springfield Massachusetts 01105
Not listed Berkley Michigan 48072
Not listed Detroit Michigan 48202
Not listed Kansas City Missouri 64111
Not listed St Louis Missouri 63108
Not listed St Louis Missouri 63139
Not listed Hillsborough New Jersey 08844
Not listed Newark New Jersey 07102
Not listed Albany New York 12208
Not listed Manhasset New York 11030
Not listed New York New York 10011-4121
Not listed New York New York 10011
Not listed The Bronx New York 10461
Not listed Chapel Hill North Carolina 27514
Not listed Charlotte North Carolina 28207
Cone Health Regional Center for Infectious Disease Greensboro North Carolina 27401
Not listed Greenville North Carolina 27858-4354
Not listed Huntersville North Carolina 28078
Not listed Winston-Salem North Carolina 27157
Not listed Cincinnati Ohio 45267
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Allegheny Health Network Pittsburgh Pennsylvania 15212
Not listed Columbia South Carolina 29203-6840
Not listed Austin Texas 78705
Not listed Bellaire Texas 77401
Not listed Dallas Texas 75202
AIDS Arms Inc Dallas Texas 75215
Not listed Dallas Texas 75235
North Texas Infectious Diseases Consultants PA Dallas Texas 75246
Not listed Fort Worth Texas 76104
Not listed Houston Texas 77004
Not listed Houston Texas 77098
Not listed Longview Texas 75605
Not listed Annandale Virginia 22003-7313
Not listed Seattle Washington 98104
Not listed Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02607956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2022 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02607956 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →